Q M He - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Q M He

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2018

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapyY-P Chen, Y-Q Wang, J-W Lv, et al.

Nature Medicine|October 4, 2000

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccineY Q Wei, Q R Wang, X Zhao, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 2001

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigenY Q Wei, M J Huang, L Yang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2018

Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapyY-P Chen, Y-Q Wang, J-W Lv, et al.

Nature Medicine|October 4, 2000

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccineY Q Wei, Q R Wang, X Zhao, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 2001

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigenY Q Wei, M J Huang, L Yang, et al.

Pageof 2